Disclosures for "Efficacy and Safety of Direct Oral Anticoagulant Reversal Agents in Intracerebral Hemorrhage: A Systematic Review and Meta-analysis"
-
Mr. Abdelkader has nothing to disclose.
-
Mr. Vallamchetla has nothing to disclose.
-
Dr. Borei has nothing to disclose.
-
Dr. Salem has nothing to disclose.
-
Dr. Lakkireddy has nothing to disclose.
-
Miss Shine has nothing to disclose.
-
Doaa Ramadan has nothing to disclose.
-
Dr. Alsaeed has nothing to disclose.
-
Dr. Thapa has nothing to disclose.
-
Dr. Muhammad has nothing to disclose.
-
Dr. Kitago has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MindMaze. The institution of Dr. Kitago has received research support from American Speech-Language Hearing Foundation. The institution of Dr. Kitago has received research support from National Institutes of Health.
-
Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Revalesio .